Li X - Search Results

1

The synthesis and evaluation of novel ALK inhibitors containing the sulfoxide structure.

Yao H, Ren Y, Wu F, Liu J, Cao L, Yan M, Li X. Yao H, et al. Among authors: li x. RSC Adv. 2024 May 31;14(25):17557-17570. doi: 10.1039/d4ra01556h. eCollection 2024 May 28. RSC Adv. 2024. PMID: 38828277 Free PMC article.

2

Design, synthesis, and evaluation of multitarget-directed resveratrol derivatives for the treatment of Alzheimer's disease.

Lu C, Guo Y, Yan J, Luo Z, Luo HB, Yan M, Huang L, Li X. Lu C, et al. Among authors: li x. J Med Chem. 2013 Jul 25;56(14):5843-59. doi: 10.1021/jm400567s. Epub 2013 Jul 8. J Med Chem. 2013. PMID: 23799643

3

The synthesis and evaluation of new butadiene derivatives as tubulin polymerization inhibitors.

Pang Y, Yan J, An B, Huang L, Li X. Pang Y, et al. Among authors: li x. Bioorg Med Chem. 2017 Jun 15;25(12):3059-3067. doi: 10.1016/j.bmc.2017.03.066. Epub 2017 Apr 1. Bioorg Med Chem. 2017. PMID: 28404525

4

Design, Synthesis, and Biological Evaluation of Novel Selenium-Containing Isocombretastatins and Phenstatins as Antitumor Agents.

Pang Y, An B, Lou L, Zhang J, Yan J, Huang L, Li X, Yin S. Pang Y, et al. Among authors: li x. J Med Chem. 2017 Sep 14;60(17):7300-7314. doi: 10.1021/acs.jmedchem.7b00480. Epub 2017 Aug 23. J Med Chem. 2017. PMID: 28792756

5

Synthesis and Biological Evaluation of Selenium-Containing 4-Anilinoquinazoline Derivatives as Novel Antimitotic Agents.

An B, Wang B, Hu J, Xu S, Huang L, Li X, Chan ASC. An B, et al. Among authors: li x. J Med Chem. 2018 Mar 22;61(6):2571-2588. doi: 10.1021/acs.jmedchem.8b00128. Epub 2018 Mar 6. J Med Chem. 2018. PMID: 29509413

6

Synthesis, Evaluation, and Mechanism Study of New Tepotinib Derivatives as Antiproliferative Agents.

Zhang NN, An BJ, Zhou Y, Li XS, Yan M. Zhang NN, et al. Molecules. 2019 Mar 25;24(6):1173. doi: 10.3390/molecules24061173. Molecules. 2019. PMID: 30934578 Free PMC article.

7

Design, synthesis and biological evaluation of novel 2,4-diaryl pyrimidine derivatives as selective EGFR^L858R/T790M inhibitors.

Li J, An B, Song X, Zhang Q, Chen C, Wei S, Fan R, Li X, Zou Y. Li J, et al. Among authors: li x. Eur J Med Chem. 2021 Feb 15;212:113019. doi: 10.1016/j.ejmech.2020.113019. Epub 2020 Nov 13. Eur J Med Chem. 2021. PMID: 33429247

8

Synthesis and evaluation of novel 2,4-diaminopyrimidines bearing a sulfoxide moiety as anaplastic lymphoma kinase (ALK) inhibition agents.

Wu F, Yao H, Li W, Zhang N, Fan Y, Chan ASC, Li X, An B. Wu F, et al. Among authors: li w, li x. Bioorg Med Chem Lett. 2021 Sep 15;48:128253. doi: 10.1016/j.bmcl.2021.128253. Epub 2021 Jul 8. Bioorg Med Chem Lett. 2021. PMID: 34245852

9

Novel third-generation pyrimidines-based EGFR tyrosine kinase inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer.

An B, Liu J, Fan Y, Nie W, Yang C, Yao H, Li W, Zhang Y, Li X, Tian G. An B, et al. Among authors: li w, li x. Bioorg Chem. 2022 May;122:105743. doi: 10.1016/j.bioorg.2022.105743. Epub 2022 Mar 16. Bioorg Chem. 2022. PMID: 35313239

10

Synthesis and evaluation of new pirfenidone derivatives as anti-fibrosis agents.

Gu C, Li W, Ju Q, Yao H, Yang L, An B, Hu W, Li X. Gu C, et al. Among authors: li w, li x. RSC Adv. 2022 May 13;12(23):14492-14501. doi: 10.1039/d2ra00990k. eCollection 2022 May 12. RSC Adv. 2022. PMID: 35702193 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184,612 results

Search Page

Filters